Premium
Thirty‐one‐year survival following chemotherapy and autologous bone marrow in malignant lymphoma
Author(s) -
Haurani Farid I.
Publication year - 1997
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/(sici)1096-8652(199705)55:1<35::aid-ajh6>3.0.co;2-4
Subject(s) - medicine , chemotherapy , lymphoma , splenectomy , malignant lymphoma , sepsis , autopsy , bone marrow , surgery , nitrogen mustard , cyclophosphamide , oncology , gastroenterology , spleen
Abstract A 21‐year‐old woman with malignant lymphoma received a large dose of nitrogen mustard followed by autologous bone marrow. She achieved a complete remission that lasted 21 years. This was followed in a span of 10 years by two relapses that responded to chemotherapy and splenectomy. Death resulted from sepsis. At autopsy, there was minimal evidence of malignant lymphoma, but evidence for side effects of chemotherapy was present. Am. J. Hematol. 55:35‐38, 1997. © 1997 Wiley‐Liss, Inc.